User menu

Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.

Bibliographic reference Koeppe, R A ; Frey, K A ; Vander Borght, Thierry ; Karlamangla, A ; Jewett, D M ; et. al. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.. In: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, Vol. 16, no.6, p. 1288-99 (1996)
Permanent URL http://hdl.handle.net/2078.1/123344
  1. Alpert N. M., Eriksson L., Chang J. Y., Bergstrom M., Litton J. E., Correia J. A., Bohm C., Ackerman R. H., Taveras J. M., Strategy for the Measurement of Regional Cerebral Blood Flow Using Short-Lived Tracers and Emission Tomography, 10.1038/jcbfm.1984.4
  2. Aquilonius S.-M., Bertröm K., Eckernäs S-Å., Hartvig P., Leenders K.L., Lundquist H., Antoni G., Gee A., Rimland A., Uhlin J., Långström B., In vivoevaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomography, 10.1111/j.1600-0404.1987.tb03582.x
  3. Bevington PR (1969) Data Reduction and Error Analysis for the Physical Sciences, New York, McGraw-Hill, pp 232–241.
  4. DaSilva Jean N., Kilbourn Michael R., In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain, 10.1016/0024-3205(92)90228-h
  5. DeJesus OT, J Nucl Med, 36, 253P (1995)
  6. Frey K. A., Koeppe R. A., Mulholland G. K., Jewett D., Hichwa R., Ehrenkaufer R. L. E., Carey J. E., Wieland D. M., Kuhl D. E., Agranoff B. W., In vivo Muscarinic Cholingeric Receptor Imaging in Human Brain with [11C]Scopolamine and Positron Emission Tomography, 10.1038/jcbfm.1992.18
  7. Frey KA, J Cereb Blood Flow Metab, 15, S38 (1995)
  8. Frost J. James, Rosier Annemie J., Reich Stephen G., Smith Justin S., Ehlers Michael D., Snyder Solomon H., Ravert Hayden T., Dannals Robert F., Positron emission tomographic imaging of the dopamine transporter with11C-WIN 35,428 reveals marked declines in mild Parkinson's disease, 10.1002/ana.410340331
  9. Garnett E. S., Firnau G., Nahmias C., Dopamine visualized in the basal ganglia of living man, 10.1038/305137a0
  10. Gjedde A., Reith J., Dyve S., Leger G., Guttman M., Diksic M., Evans A., Kuwabara H., Dopa decarboxylase activity of the living human brain., 10.1073/pnas.88.7.2721
  11. Gjedde Albert, Léger Gabriel C., Cumming Paul, Yasuhara Yoshifumi, Evans Alan C., Guttman Mark, Kuwabara Hiroto, Striatal L-DOPA Decarboxylase Activity in Parkinson's Disease In Vivo: Implications for the Regulation of Dopamine Synthesis, 10.1111/j.1471-4159.1993.tb13651.x
  12. Gilman S, J Cereb Blood Flow Metab, 15, S752 (1995)
  13. Hadjiconstantinou M., Wemlinger T. A., Sylvia C. P., Hubble J. P., Neff N. H., Aromatic L-Amino Acid Decarboxylase Activity of Mouse Striatum Is Modulated via Dopamine Receptors, 10.1111/j.1471-4159.1993.tb03503.x
  14. Henry Jean-Pierre, scherman Daniel, Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles, 10.1016/0006-2952(89)90082-8
  15. Huang Sung-Cheng, Yu Dan-Chu, Barrio Jorge R., Grafton Scott, Melega William P., Hoffman John M., Satyamurthy N., Mazziotta John C., Phelps Michael E., Kinetics and Modeling of l-6-[18F]Fluoro-DOPA in Human Positron Emission Tomographic Studies, 10.1038/jcbfm.1991.155
  16. Ikegami Hiromasa, Prasad Chandan, Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex, 10.1016/0196-9781(90)90123-m
  17. Innis R. B., Seibyl J. P., Scanley B. E., Laruelle M., Abi-Dargham A., Wallace E., Baldwin R. M., Zea-Ponce Y., Zoghbi S., Wang S., Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease., 10.1073/pnas.90.24.11965
  18. Kilbourn MR, Med Chem Res, 5, 113 (1994)
  19. Kilbourn Michael R., Sherman Phil S., Pisani Teresa, Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site, 10.1016/0014-2999(92)90216-q
  20. Kilbourn Michael, Lee Lihsueh, Borght Thierry Vander, Jewett Douglas, Frey Kirk, Binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific, 10.1016/0014-2999(95)00162-e
  21. Kish S. J., Robitaille Y., El-Awar M., Clark B., Schut L., Ball M. J., Young L. T., Currier R., Shannak K., Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy, 10.1212/wnl.42.8.1573
  22. Koeppe RA, Frontiers in Nuclear Medicine: In Vivo Imaging of Neurotransmitter Functions in Brain, Heart, and Tumors, 113 (1990)
  23. Koeppe RA, J Nucl Med, 28, 1,695 (1987)
  24. Koeppe RA, J Nucl Med, 31, 720 (1990)
  25. Koeppe R. A., Holthoff V. A., Frey K. A., Kilbourn M. R., Kuhl D. E., Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography, 10.1038/jcbfm.1991.130
  26. Koeppe Robert A., Frey Kirk A., Mulholland G. Keith, Kilbourn Michael R., Buck Alfred, Lee Kien S., Kuhl David E., [11C]Tropanyl Benzilate—Binding to Muscarinic Cholinergic Receptors: Methodology and Kinetic Modeling Alternatives, 10.1038/jcbfm.1994.13
  27. Koeppe RA, J Cereb Blood Flow Metab, 15, S651 (1995)
  28. Koeppe RA, J Nucl Med, 36, 118P (1995)
  29. Laruelle Marc, Wallace Elizabeth, Seibyl John P., Baldwin Ronald M., Zea-Ponce Yolanda, Zoghbi Sami S., Neumeyer John L., Charney Dennis S., Hoffer Paul B., Innis Robert B., Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects, 10.1038/jcbfm.1994.131
  30. Masuo Yoshinori, Pélaprat Didier, Scherman Daniel, Rostène William, [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum, 10.1016/0304-3940(90)90426-a
  31. Mintun Mark A., Raichle Marcus E., Kilbourn Michael R., Wooten G. Frederick, Welch Michael J., A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography, 10.1002/ana.410150302
  32. Naudon L., Leroux-Nicollet I., Costentin J., Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra, 10.1016/0304-3940(94)90136-8
  33. Near JA, Mol Pharmacol, 30, 252 (1986)
  34. Salmon Eric, Brooks David J., Leenders Klaus L., Turton David R., Hume Sue P., Cremer Jill E., Jones Terry, Frackowiak Richard S. J., A Two-Compartment Description and Kinetic Procedure for Measuring Regional Cerebral [11C]Nomifensine Uptake Using Positron Emission Tomography, 10.1038/jcbfm.1990.59
  35. Scherman Daniel, Raisman Rita, Ploska Alain, Agid Yves, [3H]Dihydrotetrabenazine, a New In Vitro Monoaminergic Probe for Human Brain, 10.1111/j.1471-4159.1988.tb10583.x
  36. Sharpe Lawrence G., Pilotte Nancy S., Mitchell W.Mark, De Souza Errol B., Withdrawal of repeated cocaine decreases autoradlographic [3H]mazindol-labelling of dopamine transporter In rat nucleus aecumbens, 10.1016/0014-2999(91)90804-y
  37. Borght Thierry Vander, Kilbourn Michael, Desmond Timothy, Kuhl David, Frey Kirk, The vesicular monoamine transporter is not regulated by dopaminergic drug treatments, 10.1016/0014-2999(95)00594-3
  38. Vander Borght T.M., Sima A.A.F., Kilbourn M.R., Desmond T.J., Kuhl D.E., Frey K.A., [3H]methoxytetrabenazine: A high specific activity ligand for estimating monoaminergic neuronal integrity, 10.1016/0306-4522(95)00167-h
  39. Wiener Harvey L., Hashim Audrey, Lajtha Abel, Sershen Henry, Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier, 10.1016/0014-2999(89)90418-4
  40. Wilson JM, J Neurosci, 14, 2,966 (1994)
  41. Wilson JM, J Neurosci, 16, 3,507 (1996)
  42. Zhu M. Y., Juorio A. V., Paterson I. A., Boulton A. A., Regulation of Aromatic l-Amino Acid Decarboxylase by Dopamine Receptors in the Rat Brain, 10.1111/j.1471-4159.1992.tb09765.x